pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 19·1 min read
save

AI tool guides Mayo clinicians to rapid treatment for newborn with ultra-rare disease

May 19, 2026·read at STAT ↗Positive

An AI system called the Biomedical Data Translator was used by doctors at the Mayo Clinic to search for a therapy for a newborn with an ultra-rare disease.

The infant, Jorie Kraus, was born with severe muscle weakness that affected her heart, limbs, voice box and breathing, requiring 73 days in a neonatal intensive care unit and continued developmental delays during her first two years.

The AI analysis identified a widely available medication that had not previously been linked to her condition, allowing clinicians to start treatment quickly. Within days the child showed dramatic improvement, gaining the ability to move, grasp objects and even attempt speech.

The parents described the turnaround at STAT’s Breakthrough Summit West in San Francisco, calling the effect “almost like a light switch.” The case highlights how data-driven tools can accelerate diagnosis and therapy for rare pediatric disorders.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’”

read at STAT ↗
962 words · retrieved May 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.9Mayo Clinic3National Institutes of HealthPATH
drugs
Rare Disease4
topics
Rare Disease9Cardiology2

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 2NIH rolling out streamlined website to help public find information more easilySTAT
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT
  • Sep 14Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrandBioSpace
  • Aug 20Why pediatric rare oncology outperforms in a volatile biotech marketBioSpace